Sensei Biotherapeutics, Inc. SNSE 深 滬
已收盤 09-19 16:00:00 美东时间
0.49
+0.004
+0.89%
華盛通- 最 高0.5775
- 今 開0.50
- 成交量 37.91万股
- 最 低 0.485
- 昨 收 0.4857
- 總市值 1302.61万
- 52周最高 1.94
- 市盈率 靜 --
- 換手率 1.43%
- 52周最低 0.384
- 委 比 -83.60%
- 總股本 2658.38万
- 歷史最高 26.50
- 量 比 2.77
- 振 幅 19.04%
- 歷史最低 0.384
- 每 手 1
- 風險率 0.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Dr. Jessie English Resigns from Sensei Biotherapeutics Board
Sensei Biotherapeutics (SNSE) has shared an announcement. Dr. Jessie English ha...
06-28 05:28
Sensei Biotherapeutics Unveils Updated Corporate Presentation
An update from Sensei Biotherapeutics (SNSE) is now available. Sensei Biotherap...
06-03 20:55
Sensei stock plunges 46% in wake of Phase 1 data
Sensei Biotherapeutics (NASDAQ:SNSE) shares plunged 46% Friday, the day after the biotech company released data from a Phase 1 dose escalation study of its oncology drug candidate SNS-101 in the treat...
05-25 01:42
Stephens & Co. Reiterates Overweight on Sensei Biotherapeutics, Maintains $5 Price Target
Stephens & Co. analyst Sudan Loganathan reiterates Sensei Biotherapeutics (NASDAQ:SNSE) with a Overweight and maintains $5 price target.
05-24 23:45
SCWorx, Cue Health, Sensei Biotherapeutics among healthcare movers
Gainers: Akanda (AKAN) +91%. OneMedNet (ONMD) +83%. Merus N.V MRUS +28%. SCWorx (WORX) +29%. Cue Health (HLTH) +22%. Losers: Verastem VSTM -59%. Sensei Biotherapeutics (SNSE) -46%. Genelux GNLX -40%. ...
05-24 22:00
Dow Surges 50 Points; US Durable Goods Orders Increase In April
U.S. stocks traded higher this morning, with the Dow Jones index gaining around...
05-24 21:43
Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Ross Stores, Inc. (NASDAQ:ROST) rose sharply in today's pre-market tr...
05-24 20:22
AIMD, BCG and RENB among pre-market losers
Losers: Verastem (VSTM) -57% rallies on positive data for pancreatic cancer drug combo. Sensei Biotherapeutics (SNSE) -39% presents promising clinical data from Phase 1 Dose Escalation study of SNS-10...
05-24 20:16
Sensei Biotherapeutics Inc：预计将报告剂量扩展队列的初步数据并将在2024年底之前与美国食品药品管理局举行第一阶段结束会议
Sensei Biotherapeutics Inc：预计将报告剂量扩展队列的初步数据并将在2024年底之前与美国食品药品管理局举行第一阶段结束会议
05-24 05:13
Sensei Biotherapeutics Inc：药代动力学和安全性概况验证了研究中的条件性活性方法
Sensei Biotherapeutics Inc：药代动力学和安全性概况验证了研究中的条件性活性方法
05-24 05:12
